Roots I - Search Results

1

The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.

Brockmöller J, Köchling J, Weber W, Looby M, Roots I, Neumayer HH. Brockmöller J, et al. Among authors: roots i. Br J Clin Pharmacol. 1992 Dec;34(6):499-508. Br J Clin Pharmacol. 1992. PMID: 1493082 Free PMC article.

2

Multiple-dose pharmacokinetics of ganglioside GM1 after intravenous and intramuscular administration to healthy volunteers.

Rost KL, Brockmöller J, Weber W, Roots I. Rost KL, et al. Among authors: roots i. Clin Pharmacol Ther. 1991 Aug;50(2):141-9. doi: 10.1038/clpt.1991.118. Clin Pharmacol Ther. 1991. PMID: 1868675 Clinical Trial.

3

Pharmacokinetic interaction between cyclosporin and diltiazem.

Brockmöller J, Neumayer HH, Wagner K, Weber W, Heinemeyer G, Kewitz H, Roots I. Brockmöller J, et al. Among authors: roots i. Eur J Clin Pharmacol. 1990;38(3):237-42. doi: 10.1007/BF00315023. Eur J Clin Pharmacol. 1990. PMID: 2340843

4

Pharmacokinetics of recombinant human erythropoietin after SC administration and in long-term IV treatment in patients on maintenance hemodialysis.

Neumayer HH, Brockmöller J, Fritschka E, Roots I, Scigalla P, Wattenberg M. Neumayer HH, et al. Among authors: roots i. Contrib Nephrol. 1989;76:131-41; discussion 141-2. doi: 10.1159/000417889. Contrib Nephrol. 1989. PMID: 2582778 No abstract available.

5

The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.

Bauer S, Brockmöller J, Kewitz H, Roots I. Bauer S, et al. Among authors: roots i. Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):540-2. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1283385

6

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.

Rost KL, Brösicke H, Brockmöller J, Scheffler M, Helge H, Roots I. Rost KL, et al. Among authors: roots i. Clin Pharmacol Ther. 1992 Aug;52(2):170-80. doi: 10.1038/clpt.1992.126. Clin Pharmacol Ther. 1992. PMID: 1505152 Clinical Trial.

7

Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Brockmöller J, Staffeldt B, Roots I. Brockmöller J, et al. Among authors: roots i. Eur J Clin Pharmacol. 1991;40(4):387-92. doi: 10.1007/BF00265849. Eur J Clin Pharmacol. 1991. PMID: 2050173

8

Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.

Kerb R, Brockmöller J, Staffeldt B, Ploch M, Roots I. Kerb R, et al. Among authors: roots i. Antimicrob Agents Chemother. 1996 Sep;40(9):2087-93. doi: 10.1128/AAC.40.9.2087. Antimicrob Agents Chemother. 1996. PMID: 8878586 Free PMC article. Clinical Trial.

9

Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment.

Püchler K, Eckl KM, Fritsche L, Renneisen K, Neumayer HH, Sierakowski B, Lavrijssen AT, Thomsen T, Roots I. Püchler K, et al. Among authors: roots i. Br J Clin Pharmacol. 1997 Dec;44(6):531-6. doi: 10.1046/j.1365-2125.1997.t01-1-00622.x. Br J Clin Pharmacol. 1997. PMID: 9431827 Free PMC article. Clinical Trial.

10

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.

Mück W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S, Johne A, Bauer S, Budde K, Roots I, Neumayer HH, Kuhlmann J. Mück W, et al. Among authors: roots i. Clin Pharmacol Ther. 1999 Mar;65(3):251-61. doi: 10.1016/S0009-9236(99)70104-9. Clin Pharmacol Ther. 1999. PMID: 10096257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters